Cargando…
Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
Cholecystokinin (CCK) receptors are overexpressed in numerous human cancers, like medullary thyroid carcinomas, small cell lung cancers and stromal ovarian cancers. The specific receptor-binding property of the endogenous ligands for these receptors can be exploited by labeling peptides with a radio...
Autores principales: | Roosenburg, Susan, Laverman, Peter, van Delft, Floris L., Boerman, Otto C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205271/ https://www.ncbi.nlm.nih.gov/pubmed/20198494 http://dx.doi.org/10.1007/s00726-010-0501-y |
Ejemplares similares
-
Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011) -
Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
por: Ashurst, H Louise, et al.
Publicado: (2008) -
The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
por: Smith, Jill P., et al.
Publicado: (2016) -
Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr
por: Boerman, Otto C., et al.
Publicado: (2011) -
Abnormal gastric morphology and function in CCK-B/gastrin receptor-deficient mice.
por: Rindi, G., et al.
Publicado: (1998)